Kintor Pharmaceutical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	52.86	147.42	445.5	865.08	930.15	1,066
Short-Term Investments	-	1.27	12.56	11.88	126.58	327.53
Cash & Short-Term Investments	52.86	148.69	458.05	876.96	1,057	1,393
Cash Growth	-84.16%	-67.54%	-47.77%	-17.01%	-24.15%	607.84%
Accounts Receivable	7.06	-	-	-	-	-
Other Receivables	-	15.65	6.48	-	-	-
Receivables	7.06	15.65	6.48	-	-	-
Inventory	3	2.22	-	603.5	351.36	-
Restricted Cash	0.43	0.43	0.43	5.64	1.66	-
Other Current Assets	-	4.75	7.6	21.77	116.15	27.49
Total Current Assets	63.35	171.73	472.56	1,508	1,526	1,421
Property, Plant & Equipment	168.35	174.23	221.84	282.48	262.3	186.68
Long-Term Investments	16.09	16.57	18	17.95	-	-
Other Intangible Assets	143.08	148.95	148.94	235.65	235.62	209.76
Other Long-Term Assets	1.03	3.65	7.9	11.2	44.17	34.42
Total Assets	391.9	515.13	869.23	2,055	2,068	1,851
Accounts Payable	49.01	40.96	81.6	180.4	172.96	28.81
Accrued Expenses	3.11	6.68	17.32	19.89	25.12	16.38
Short-Term Debt	41.13	14.38	20	40	-	79.9
Current Portion of Long-Term Debt	45.85	97.38	93.7	58.9	7.4	3.7
Current Portion of Leases	0.41	1.25	4.53	4.44	2.07	2.71
Current Unearned Revenue	-	-	-	-	-	0.36
Other Current Liabilities	3.42	6.03	7.58	14.5	12.2	37.47
Total Current Liabilities	142.94	166.68	224.73	318.13	219.74	169.33
Long-Term Debt	-	20	133.4	177.6	147.5	134.9
Long-Term Leases	-	-	2.29	5.45	2.76	0.49
Long-Term Unearned Revenue	3.36	3.32	19.66	19.95	4.01	-
Long-Term Deferred Tax Liabilities	29.59	31.04	31.04	38.82	38.82	38.82
Total Liabilities	175.89	221.05	411.12	559.95	412.83	343.54
Common Stock	0.32	0.32	0.32	0.32	0.27	0.26
Additional Paid-In Capital	4,233	4,210	4,182	4,104	3,359	-
Retained Earnings	-4,023	-3,940	-3,785	-2,724	-1,769	-927.38
Comprehensive Income & Other	5.5	23.58	60.73	114.77	65.49	2,435
Shareholders' Equity	216.01	294.08	458.11	1,495	1,655	1,508
Total Liabilities & Equity	391.9	515.13	869.23	2,055	2,068	1,851
Total Debt	87.4	133.01	253.92	286.39	159.73	221.7
Net Cash (Debt)	-34.54	15.68	204.13	590.57	897	1,171
Net Cash Growth	-	-92.32%	-65.43%	-34.16%	-23.43%	782.66%
Net Cash Per Share	-0.08	0.04	0.48	1.57	2.52	3.79
Filing Date Shares Outstanding	442.36	434.2	439.4	447.5	387.59	369.39
Total Common Shares Outstanding	442.36	434.2	439.4	447.5	387.59	369.39
Working Capital	-79.59	5.05	247.83	1,190	1,306	1,251
Book Value Per Share	0.49	0.68	1.04	3.34	4.27	4.08
Tangible Book Value	72.93	145.13	309.17	1,260	1,420	1,298
Tangible Book Value Per Share	0.16	0.33	0.70	2.81	3.66	3.51
Buildings	-	89.23	89.23	89.23	57.66	57.66
Machinery	-	58.91	58.7	58.24	46.78	29.88
Construction In Progress	-	109.24	109.24	105.66	125.74	92.29

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.